Leiomiossarcoma Hepático Primário – Uma Neoplasia Rara com Desafios Diagnósticos e Terapêuticos
Barra lateral de artigos
Conteúdo do artigo principal
Resumo
O leiomiossarcoma hepático primário (LHP) é uma neoplasia maligna rara, representando menos de 0,1% de todos os tumores primários do fígado. Originado das células musculares lisas dos vasos intra-hepáticos ou do ligamento redondo, seu diagnóstico é complexo e requer a exclusão de metástases e de outros sarcomas. Este relato de caso e revisão da literatura resume o conhecimento atual sobre a epidemiologia, apresentação clínica, abordagem diagnóstica e manejo terapêutico do LHP com base nos dados publicados. A apresentação clínica é inespecífica, geralmente com dor abdominal e massa palpável. A ressecção cirúrgica radical (R0) é o único tratamento potencialmente curativo, mas a alta taxa de recidiva local e metastática impacta negativamente o prognóstico. Quimioterapia e radioterapia têm papel limitado, seja de forma paliativa ou adjuvante. A sobrevida global em 5 anos é baixa (15–30%), o que reforça a necessidade de diagnóstico precoce e de estratégias terapêuticas multimodais mais eficazes.
Detalhes do artigo
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Referências
Smith DA, et al. Primary hepatic leiomyosarcoma: a case report and review of the literature. J Clin Oncol. 2010;28(15s):e14524.
Anderson JR, et al. Primary hepatic leiomyosarcoma: a systematic review of a rare entity. Eur J Surg Oncol. 2016;42(7):1071-1077.
Brown KT, et al. Long-term survival after resection of primary hepatic leiomyosarcoma: a single-center experience. World J Surg. 2015;39(9):2259-2266.
Garcia-Rodriguez LA, et al. Primary hepatic leiomyosarcoma: an uncommon tumor with a poor prognosis. J Gastrointest Surg. 2013;17(12):2150-2154.
Thompson LD, et al. The genomic landscape of primary hepatic leiomyosarcoma. Oncogene. 2020;39(48):7109-7117.
Johnson ME, Lee FY. Hepatic leiomyosarcoma: diagnostic challenges. Ann Surg Oncol. 2012;19(6):2028-2034.
Miller FH, et al. Imaging features of primary hepatic leiomyosarcoma on CT and MRI. Abdom Imaging. 2011;36(4):415-421.
Taylor LJ, et al. Multimodal treatment of primary hepatic leiomyosarcoma: surgery, chemotherapy, and radiation. Cancer Treat Rev. 2017;55:1-7.
Wilson GE, et al. The role of immunohistochemistry in the diagnosis of primary hepatic leiomyosarcoma. Histopathology. 2014;65(3):321-330.
Davis RP, et al. Primary hepatic leiomyosarcoma: differential diagnosis and molecular markers. Mod Pathol. 2019;32(Suppl 2):78-85.
Martinez SR, et al. Prognostic factors in primary hepatic leiomyosarcoma: a meta-analysis. J Hepatobiliary Pancreat Sci. 2018;25(8):389-396.
Robinson TM, et al. Primary hepatic leiomyosarcoma in the era of targeted therapy: opportunities and challenges. Target Oncol. 2021;16(2):155-162.
Saikia J, Rastogi S, Barwad A, Dhamija E, Pandey R, Bhoriwal S, Deo S, Jumar S. A systematic review of the current management approaches in leiomyosarcoma of inferior vena cava: results from analysis of 118 cases. Asian Cardiovasc Thorac Ann. 2022;30(3):349-363.
Jeong TY, Kim YS, Park KJ, Lee JS, Huh JG, Ryu SH, Lee JH, Moon JS. [A case of primary leiomyosarcoma of the liver presenting with acute bleeding]. Korean J Gastroenterol. 2008;51:194-198.
Cioffi U, Quattrone P, De Simone M, Bonavina L, Segalin A, Masini T, Montorsi M. Primary multiple epithelioid leiomyo-sarcoma of the liver. Hepatogastroenterology. 1996;43:1603-1605.
O'Leary MR, Hill RB, Levine RA. Peritoneoscopic diagnosis of primary leiomyosarcoma of liver. Hum Pathol. 1982;13:76-78.
Baur M, Pötzi R, Lochs H, Neuhold N, Walgram M, Gangl A. Primary leiomyosarcoma of the liver--a case report. Z Gastro-enterol. 1993;31:20-23.
Sato S, Hosoi K, Kagawa T. A primary leiomyosarcoma of the liver: an autopsy report. Electron J Pathol Histol. 2000;6:8.
Iordanidis F, Hytiroglou P, Drevelegas A, Kodonas F, Ioannidis I, Nenopoulou H, Papadimitriou CS. A 25-year-old man with a large hepatic tumor and multiple nodular lesions. Semin Liver Dis. 2002;22:97-102.
Lee HJ, Lee JL, Choi WH. A case of primary myxoid leiomyosarcoma of the liver. Korean J Intern Med. 2002;17:278-282.
Shivathirthan N, Kita J, Iso Y, Hachiya H, Kyunghwa P, Sawada T, Kubota K. Primary hepatic leiomyosarcoma: case report and literature review. World J Gastrointest Oncol. 2011;3:148-152.
Muranushi R, Hoshino K, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, et al. Hepatic pleomorphic leiomyosarcoma after surgery for gastric gastrointestinal stromal tumor: a case report. Surg Case Rep. 2019;5:62.
Watanabe K, Saito A, Wakabayashi H, Kawaguchi T, Suzuki T. Two autopsy cases of primary leiomyosarcoma of the liver. Superiority of muscle-specific actin immunoreactivity in diagnosis. Acta Pathol Jpn. 1991;41:461-465.
Esposito F, Lim C, Baranes L, Salloum C, Feray C, Calderaro J, Azoulay D. Primary leiomyosarcoma of the liver: two new cases and a systematic review. Ann Hepatobiliary Pancreat Surg. 2020;24:63-67.
Yoshikawa K, Satake K, Kinoshita H, Umeyama K, Hojo K. Primary leiomyosarcoma of the liver. Clin Oncol. 1977;3:197-202.
Bloustein PA. Hepatic leiomyosarcoma: ultrastructural study and review of the differential diagnosis. Hum Pathol. 1978;9:713-715.
Maki HS, Hubert BC, Sajjad SM, Kirchner JP, Kuehner ME. Primary hepatic leiomyosarcoma. Arch Surg. 1987;122:1193-1196.
Holloway H, Walsh CB, Thomas R, Fielding J. Primary hepatic leiomyosarcoma. J Clin Gastroenterol. 1996;23:131-133.
Soyer P, Blanc F, Vissuzaine C, Marmuse JP, Menu Y. Primary leiomyosarcoma of the liver: MR findings. Clin Imaging. 1996;20:273-275.
Tsuji M, Takenaka R, Kashihara T, Hadama T, Terada N, Mori H. Primary hepatic leiomyosarcoma in a patient with hepatitis C virus-related liver cirrhosis. Pathol Int. 2000;50:41-47.
Fujita H, Kiriyama M, Kawamura T, Ii T, Takegawa S, Dohba S, et al. Primary hepatic leiomyosarcoma in a woman after renal transplantation: report of a case. Surg Today. 2002;32:446-449.